In a significant move within the healthtech sector, Altavo has secured a €5M Series A investment. By attracting leading fund Occident and others including Novalis Biotech and High-Tech Gründerfonds, the AI-driven voice rehabilitation firm solidifies its financial position.

This influx of capital showcases investor confidence and is earmarked for bolstering Altavo's growth and enhancing its product offerings, marking a promising leap forward for the Germany-based innovator.